US : FDA approves drug to treat MRSA
US : FDA approves drug to treat MRSA

US : FDA approves drug to treat MRSA

Researchers may have come up with a new treatment for serious skin infections like MRSA.

Scientists at Duke University say in a 3-year study, a single, intravenous infusion of the drug Oritavancin was just as effective in treating resistant infections as the current standard drug, Vancomycin, which is taken twice a day for up to ten days.

Researchers say a key advantage to the new drug is that it can stay in the body for a longer period of time. The study author says, “you can be discharged from the ER to go back home and gradually cure the infection over the next 7 to 10 days.

The drug maker funded the study and has submitted the results to the FDA. Researchers say there were minor side effects, including nausea and headaches.


  • About News

    Web articles – via partners/network co-ordinators. This website and its contents are the exclusive property of ANGA Media Corporation . We appreciate your feedback and respond to every request. Please fill in the form or send us email to: [email protected]

    Check Also

    Brian Laundrie news: 'We're not wasting our time,' police commander says

    Brian Laundrie news: ‘We’re not wasting our time,’ police commander says

    VENICE, Fla. – Six days into the search for Brian Laundrie, police in North Port …

    Leave a Reply